Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Allogene Therapeutics Inc shares valued at $78,844 were purchased by Douglas Earl Martin on Aug 21 ’24. At $2.79 per share, Douglas Earl Martin acquired 28,310 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, MESSEMER DEBORAH M. sold 18,641 shares, netting a total of over 42,488 in proceeds. Following the sale of shares at $2.28 each, the insider now holds 166,765 shares.
Before that, Humer Franz B had sold 11,200 shares from its account. In a trade valued at $26,181, the Director traded Allogene Therapeutics Inc shares for $2.34 each. Upon closing the transaction, the insider’s holdings decreased to 11,200 shares, worth approximately $0.73 million.
Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in late May. As of January 05, 2024, JMP Securities has decreased its “Mkt outperform” rating to a “Mkt perform” for ALLO. Earlier on January 05, 2024, Guggenheim downgraded its rating. Their new recommendation was “a Neutral” for ALLO stock which previously was a “a Buy”.
Analyzing ALLO Stock Performance
During the last five days, there has been a surge of approximately 7.95%. Over the course of the year, Allogene Therapeutics Inc shares have dropped approximately -11.21%. Shares of the company reached a 52-week high of $5.78 on 03/08/24 and a 52-week low of $2.01 on 07/05/24. A 50-day SMA is recorded $2.63, while a 200-day SMA reached $3.21. Nevertheless, trading volume fell to 1.3 million shares from 1.76 million shares the previous day.
Support And Resistance Levels for Allogene Therapeutics Inc (ALLO)
According to the 24-hour chart, there is a support level at 2.74, which, if violated, would cause prices to drop to 2.62. In the upper region, resistance lies at 2.92. The next price resistance is at 2.98. RSI (Relative Strength Index) is 56.21 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.04, which suggests the price will decrease in the coming days. Percent R is at 26.71%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
